Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Experts say semaglutide may be a much-needed treatment option for a liver disease with few current therapies. Ozempic is effective in treating a severe form of liver disease that affects millions ...

The research team plans to monitor 1,200 patients over five years to assess long-term benefits and safety of Ozempic in liver disease treatment.

Semaglutide, sold under brand names like Ozempic, Rybelsus ... process could transform how we approach advanced liver disease treatment. Participants receiving semaglutide experienced an average ...

patients may finally have a real treatment that goes beyond just symptom management. Should everyone with liver disease be on Ozempic? Not so fast. While this is exciting news, semaglutide isn’t ...

a serious form of fatty liver disease. The use of semaglutide, a medication from the class of GLP-1 receptor agonists, has become increasingly popular. The brands Rybelsus and Ozempic are ...

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease ... maker of Ozempic and Wegovy ...

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.